Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DEBORAH M. MESSEMER Insider Profile
4 Followers
DEBORAH M. MESSEMER, Director at Allogene Therapeutics, holds 17.54K shares in TPG (Ticker: TPG), holds 166.76K shares in Allogene Therapeutics (Ticker: ALLO), holds 13.98K shares in PayPal Holdings (Ticker: PYPL). Most recently, DEBORAH M. MESSEMER Sold ― shares of TPG on Jul 17, 2024 for an estimated value of 190.30K.
DEBORAH M. MESSEMER Allogene Therapeutics (ALLO)Director
Allogene Therapeutics (ALLO)
Director
Ranked #85,427 out of 99,335 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-42.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that DEBORAH M. MESSEMER holds in companies
Most Profitable Insider Trade
The most profitable trade made by DEBORAH M. MESSEMER
DEBORAH M. MESSEMER's Trading History
Allogene Therapeutics
Jun 20, 2024
Director
Uninformative Sell
42.32K
$353.54K
PayPal Holdings
May 24, 2024
Director
Informative Sell
272.62K
$1.18M
TPG
Jul 17, 2024
Director
Informative Sell
190.30K
$1.19M
List of latest transactions for each holding click on a transaction to see DEBORAH M. MESSEMER's performance on stock
You May Also Like
DEBORAH M. MESSEMER insider profile FAQ
What is the percentage of profitable transactions made by DEBORAH M. MESSEMER?
The percentage of profitable transactions made by DEBORAH M. MESSEMER is 0%.
What is the average return per transaction made by DEBORAH M. MESSEMER?
The average return per transaction made by DEBORAH M. MESSEMER is -42.20%.
What stocks does DEBORAH M. MESSEMER hold?
DEBORAH M. MESSEMER holds: ALLO, PYPL, TPG stocks.
What was DEBORAH M. MESSEMER’s latest transaction?
DEBORAH M. MESSEMER latest transaction was an Informative Sell of $190.30K.
What was DEBORAH M. MESSEMER's most profitable transaction?
DEBORAH M. MESSEMER’s most profitable transaction was an Informative Sell of PYPL stock on May 24, 2024. The return on the trade was -34.60%.
What is DEBORAH M. MESSEMER's role in Allogene Therapeutics?
DEBORAH M. MESSEMER's role in Allogene Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.